Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 17/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.42 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 6/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 5/20 | 0.42 |
| ▸ | NAMPT | P43490 | 1/20 | 0.41 |
| ▸ | RORC | P51449 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25017865 | 1.00 | F10 (0.47) | F10ITGB3ITGA2BF2PRSS1 | |
| SCHEMBL25017860 | 0.86 | F10 (0.51) | F10ITGB3ITGA2BF2PRSS1 | |
| SCHEMBL25017845 | 0.84 | F10 (0.47) | F10ITGB3ITGA2BF2PRSS1 | |
| SCHEMBL25017858 | 0.78 | F10 (0.50) | F10ITGB3ITGA2BF2PRSS1 | |
| SCHEMBL25015989 | 0.78 | F2 (0.50) | F10ITGB3ITGA2BF2PRSS1 | |
| SCHEMBL25016794 | 0.77 | F10 (0.47) | F10ITGB3ITGA2BF2PRSS1 | |
| SCHEMBL25016792 | 0.77 | F10 (0.47) | F10ITGB3ITGA2BF2PRSS1 | |
| SCHEMBL25016768 | 0.76 | F10 (0.72) | F10ITGB3ITGA2BF2 | |
| SCHEMBL25017861 | 0.76 | F10 (0.45) | F10ITGB3ITGA2BF2PRSS1 | |
| SCHEMBL25017827 | 0.75 | ITGB3 (0.61) | F10ITGB3ITGA2BF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230043159-A1 | MATRIPTASE 2 INHIBITORS AND USES THEREOF | DISC MEDICINE, INC. | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230043159-A1 | MATRIPTASE 2 INHIBITORS AND USES THEREOF | MMP7, MATR3, SPINT2 | F10 1548/4885ITGB3 2374/4885ITGA2B 2429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.